ORAL COMPOSITION EXHIBITING ENHANCE UPTAKE
    1.
    发明申请
    ORAL COMPOSITION EXHIBITING ENHANCE UPTAKE 审中-公开
    口服组合物展示强化摄取

    公开(公告)号:WO9834587A8

    公开(公告)日:1999-12-02

    申请号:PCT/US9802567

    申请日:1998-02-10

    Abstract: An oral composition and method for use thereof, comprising in an orally acceptable vehicle, an effective antiplaque amount of a noncationic antibacterial agent, and an anionic copolymer formed from monomers of which about 40 to about 90 % by weight are hydrophilic type capable of attachment to oral surfaces and about 10 to about 60 % by weight are of a hydrophobic type; such oral composition being effective in increasing the uptake of the antibacterial compound to dental tissue so as to enhance the therapeutic efficacy of the administered antibacterial compound.

    Abstract translation: 一种口服组合物及其使用方法,其包含口腔可接受的媒介物,有效抗菌斑剂量的非阳离子抗菌剂和由约40至约90重量%的单体形成的阴离子共聚物,其是能够附着于 约10至约60重量%的口腔表面是疏水型; 这种口服组合物有效地增加抗菌化合物对牙齿组织的摄取,从而提高所施用的抗菌化合物的治疗功效。

    VINYLLACTAM COPOLYMERS USED AS GAS HYDRATE INHIBITORS
    2.
    发明申请
    VINYLLACTAM COPOLYMERS USED AS GAS HYDRATE INHIBITORS 审中-公开
    VINYLLACTAMCOPOLYMERISATE作为气体水合物抑制剂

    公开(公告)号:WO2004042190A3

    公开(公告)日:2004-07-08

    申请号:PCT/EP0311928

    申请日:2003-10-28

    CPC classification number: C09K8/52 C09K2208/22

    Abstract: The invention relates to the use of copolymers as gas hydrate inhibitors, whereby these copolymers are synthesized from: 40 to 99.5 % by weight of at least one ethylenically unsaturated cyclic lactam A; 0.5 to 60 % by weight of monomers B having a solubility in water of less than 10 parts by weight of monomers in 100 parts by weight of water, and; 0 to 50 % by weight of other monomers C.

    Abstract translation: of40使用内置了高达99.5重量%的至少一种烯键式不饱和的,环状内酰胺A的%为0.5〜60重量%,在100重量%的具有以单体重量计小于10份的水溶解度单体B的%共聚物。 通过水份,AND0至50重量的其他单体C作为气体水合物抑制剂%。

    VINYLLACTAM COPOLYMERS USED AS GAS HYDRATE INHIBITORS

    公开(公告)号:CA2504834A1

    公开(公告)日:2004-05-21

    申请号:CA2504834

    申请日:2003-10-28

    Applicant: BASF AG

    Abstract: The invention relates to the use of copolymers as gas hydrate inhibitors, whereby these copolymers are synthesized from: 40 to 99.5 % by weight of at least one ethylenically unsaturated cyclic lactam A; 0.5 to 60 % by weight o f monomers B having a solubility in water of less than 10 parts by weight of monomers in 100 parts by weight of water, and; 0 to 50 % by weight of other monomers C.

    6.
    发明专利
    未知

    公开(公告)号:ES2197343T3

    公开(公告)日:2004-01-01

    申请号:ES97924000

    申请日:1997-05-26

    Applicant: BASF AG

    Abstract: The use of water-soluble copolymers which comprise(a) 5-20 mol % of N-vinylimidazole or 4-vinylpyridine N-oxide units,(b) 95-50 mol % of N-vinylpyrrolidone, N-vinyloxazolidone, methyl-N-vinylimidazole units or mixtures thereof and(c) 0-30 mol % of other monoethylenically unsaturated monomer units,and have an average molecular weight Mw of more than 50,000 as color transfer inhibitors in detergents.

    9.
    发明专利
    未知

    公开(公告)号:DE59709864D1

    公开(公告)日:2003-05-22

    申请号:DE59709864

    申请日:1997-05-26

    Applicant: BASF AG

    Abstract: The use of water-soluble copolymers which comprise(a) 5-20 mol % of N-vinylimidazole or 4-vinylpyridine N-oxide units,(b) 95-50 mol % of N-vinylpyrrolidone, N-vinyloxazolidone, methyl-N-vinylimidazole units or mixtures thereof and(c) 0-30 mol % of other monoethylenically unsaturated monomer units,and have an average molecular weight Mw of more than 50,000 as color transfer inhibitors in detergents.

Patent Agency Ranking